Nerve-repair startup Renerva said today it has received $2.4 million in funding from the U.S. Department of Defense.
The Pittsburgh company is developing a periheral nerve matrix (PNM), an injectable gel derived from porcine tissue to help repair and regenerate injured peripheral nerves. The Medical Technology Enterprise Consortium (MTEC) Award award will enable Renerva to complete its preclinical program and begin human clinical trials.
Get the full story on our sister site, MassDevice.